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Burkholderia 
pseudomallei 
Isolates in 
2 Pet Iguanas, 
California, USA
Ashley M. Zehnder,1 Michelle G. Hawkins,  
Marilyn A. Koski, Barry Lifland, Barbara A. Byrne, 
Alexandra A. Swanson, Michael P. Rood,  
Jay E. Gee, Mindy Glass Elrod, Cari A. Beesley, 
David D. Blaney, Jean Ventura,  
Alex R. Hoffmaster, and Emily S. Beeler
Burkholderia pseudomallei,	 the	 causative	 agent	 of	 
melioidosis,	 was	 isolated	 from	 abscesses	 of	 2	 pet	 green	
iguanas	 in	 California,	 USA.	 The	 international	 trade	 in	 
iguanas	may	contribute	to	importation	of	this	pathogen	into	
countries	where	it	is	not	endemic	and	put	persons	exposed	
to	these	animals	at	risk	for	infection.
Burkholderia pseudomallei, a gram-negative bacterium, is the causative agent of melioidosis. Melioidosis is en-
demic in countries in Southeast Asia and in northern Aus-
tralia, and has been sporadically reported from Central and 
South America (1). In the United States, most case-patients 
have traveled to disease-endemic areas (2).
B. pseudomallei infection occurs through direct cuta-
neous inoculation with soil or water containing B. pseudo-
mallei and through ingestion or inhalation of aerosolized 
bacteria. In humans, the incubation period is typically 
1–21 days, but some patients demonstrate clinical signs 
years after exposure (1).  Acute melioidosis can manifest 
as a severe pneumonia and septicemia, with death rates 
>40% in countries where access to medical care is lim-
ited. In chronic melioidosis, abscesses occur in various 
organs, including the lungs, liver, spleen, and cutaneous 
sites (1,3). In animals, abscesses and acute illness are 
common (4).
B. pseudomallei is classified by US federal agencies as 
a tier 1 select agent. Tier 1 agents are believed to pose the 
greatest threat for deliberate misuse and potential harm to 
public health. Multiple regulations restrict access to these 
agents and reduce the risk of their release from secure set-
tings (5). Infection is generally diagnosed by culture. Com-
mercially available bacterial identification systems may 
provide initial identification; however, B. pseudomallei 
may be misidentified by some systems (6). Other identifi-
cation tests are available, including PCR and antigen detec-
tion; these are not commonly used outside disease-endemic 
regions (3,7,8).
 Case Reports
A 2.5-year-old female green iguana (Iguana iguana) 
was referred to the William R. Pritchard Veterinary Medi-
cal Teaching Hospital, University of California, Davis, in 
2007 for evaluation of a coelomic mass and leukocytosis 
(40.0–42.0 × 103 cells/mL [reference 3–10 × 103 cells/
mL]). Radiographs and ultrasound results confirmed mul-
tiple hepatic masses. Initial aspiration and culture of 1 
mass yielded 3 colonies of a Bacillus spp. Empirical anti-
microbial drug therapy with ceftazidime (20 mg/kg intra-
muscularly every 48 h for 30 d) was initiated. The iguana 
was brought for treatment of additional coelomic masses 6 
months later. Aspiration of the masses and culture of the 
sample yielded small colonies of suspected B. pseudomal-
lei; blood samples collected for culture were negative for 
the organism. Results of in-house biochemical testing and 
PCR were consistent with B. pseudomallei or B. mallei. 
The culture was submitted to Stanford University School 
of Medicine, Department of Comparative Medicine. The 
Biolog Dangerous Pathogens Database ID system (http://
info.biolog.com/VetCampaign_vet_alt.html) identified B. 
pseudomallei. Laboratory Response Network PCR proto-
cols and biochemical testing performed at the Santa Clara 
Public Health Laboratory (Santa Clara, CA, USA) con-
firmed B. pseudomallei. 
The isolate was then sent to the Centers for Disease 
Control and Prevention (CDC) for further characterization 
by multilocus sequence typing (MLST), a method of molec-
ular subtyping that compares sequences from 7 housekeep-
ing genes (9). This isolate’s sequence type (ST) isolate is 
ST518 (http://bpseudomallei.mlst.net/). No environmental 
testing was performed. Treatment included trimethoprim/
sulfamethoxazole (20 mg/kg by mouth every 24 h) and 
doxycycline (10 mg/kg by mouth every 24 h), according to 
published treatment regimens and in-house susceptibility 
testing (7,10–12). Against recommendations, therapy was 
discontinued by the owner after 3 months. Re-evaluation 
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of the patient 13 months after diagnosis revealed persistent 
leukocytosis. Euthanasia of the iguana was recommended, 
but the owner declined. The iguana died at home ≈2.5 years 
after initial diagnosis; a necropsy was not permitted.
In December 2012, a 1.6-year-old female green iguana 
was brought to a veterinarian in Los Angeles County, Cali-
fornia, ≈400 miles south of the first case. An abscess, ≈40 
mm in diameter, appeared on the iguana’s left shoulder 2 
days after it fell from a height of 1 meter. The abscess was 
surgically removed and submitted to a commercial veteri-
nary laboratory, which cultured β-hemolytic Streptococcus 
spp. and large numbers of unidentified gram-negative rods. 
Marbofloxacin (7.5 mg/kg by mouth, every other day, for 
40 days) was prescribed. The laboratory forwarded the un-
identified isolate to the Sacramento Public Health Labora-
tory, which identified it as B. pseudomallei by using Labo-
ratory Response Network PCR protocols and biochemical 
testing. The isolate was forwarded to CDC where MLST 
was performed. The isolate was ST518, which matched the 
isolate from the first infected iguana and another isolate re-
covered from a tourist from Arizona who had been infected 
in Costa Rica in 2010 (http://bpseudomallei.mlst.net/).
Staff from Los Angeles County Department of Public 
Health visited the iguana owner’s home 3 weeks after the 
iguana completed marbofloxacin treatment. The iguana had 
a firm swelling on the left shoulder that was ≈25-mm in 
diameter, with a central flat, red crust that was 5 mm in di-
ameter (Figure). The owner had not yet disinfected the ani-
mal’s housing. Sterile rayon swabs in liquid Amies medi-
um were used to collect swab specimens from the iguana: 1 
from the bottom of the feet, 1 from inside the cloacal open-
ing (vent), and 2 from the red crust on the shoulder swell-
ing. Four specimens were also collected from the iguana’s 
housing: 50 mL of water from its aluminum water bowl, a 
fecal sample in the water, a cloth containing feces from its 
tank, and a biofilm sample, recovered with a sterile poly-
urethane foam swab, from the inside of the emptied water 
bowl. The 8 samples underwent culture and type III secre-
tion system real-time PCR for B. pseudomallei (13). PCR 
results from the water sample, the water bowl biofilm, and 
a shoulder swab specimen were positive. B. pseudomallei 
was cultured from the second shoulder swab specimen. 
CDC confirmed the isolate as B. pseudomallei. The owner 
euthanized the iguana, and tissue samples were collected in 
a Biosafety Level 3 cabinet at Los Angeles County Depart-
ment of Public Health. The iguana’s shoulder swelling had 
grown to ≈30 mm in diameter, and multiple 5-mm yellow 
masses were found in the iguana’s liver, lungs, and spleen.
Both owners stated that the iguanas had been purchased 
at young ages from local pet stores, had been kept indoors, 
and had not left California. The pathogen’s zoonotic po-
tential was discussed with the owners and veterinarians in 
both cases. The owners were advised to consult with their 
physicians about potential exposure and were advised to 
use personal protective equipment (e.g., gloves, masks, 
and dedicated clothing) when handling the pets, to wash 
their hands afterward, and to disinfect the pets’ environ-
ment with 0.5%–1% sodium hypochlorite. No pet-related 
B. pseudomallei infections in humans have been reported.
Conclusions
This report identifies B. pseudomallei isolates in 2 pet 
green iguanas and the environment of one of the infect-
ed pets. Their clinical disease developed when they were 
adults and was refractory to antimicrobial drug treatment. 
The second iguana suffered mild trauma shortly before its 
Figure.	Abscess	on	shoulder	of	iguana	infected	with	Burkholderia pseudomallei,	California,	USA,	2013.	A)	Lateral	view.	B)	Dorsal	view.	
Photo	was	taken	at	the	time	of	sampling	surface	of	animal	and	its	environment.
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abscess appeared. Human case reports suggest that trauma 
may trigger the onset of disease (14).
Most green iguanas entering the pet trade in the United 
States originate from Central America (15). Both iguanas 
in this report  and a person exposed in Costa Rica were 
infected with isolates with an identical sequence type by 
MLST. These results suggest that the iguanas were infected 
in Central America and experienced prolonged incubation 
periods (>1.5 years).
Positive PCR results from the water bowl suggest 
environmental contamination. The open abscess on the 
second iguana tested positive by both PCR and culture 
and was the likely source. However, negative PCR and 
culture results from the iguana’s vent, feet, and feces 
in the water bowl suggest contamination may not have 
been widespread.
Reptile owners, sellers, veterinarians, and staff in vet-
erinary laboratories should be aware that green iguanas 
with abscesses may be infected with B. pseudomallei and 
that they should use appropriate personal protective equip-
ment when handling them. Laboratories accepting samples 
from animals possibly infected with B. pseudomallei should 
anticipate risks associated with culturing this bacteria and 
take steps to protect workers.
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